Skip to main content
. 2020 Jun 5;22:131. doi: 10.1186/s13075-020-02203-1

Table 1.

Demographic and clinical features

Parameter Total (n = 216) Patients without PAI (n = 160) Patients with PAI (n = 56) P*
General information
 Female:male 178:37 130:30 48:7 0.41
 Age at diagnosis (years, mean ± SD) 35.19 ± 14.75 34.23 ± 15.05 37.96 ± 13.57 0.11
 Active status (n (%)) 118 (54.63) 91 (56.88) 27 (48.21) 0.63
 Observational period (month, quartile) 12 (7, 25) 12 (4.5, 24) 11 (6.7, 27) 0.43
Clinical symptoms
 Headache/dizziness (n (%)) 87 (40.28) 73 (45.63) 14 (25.00) 0.023
 Weakness (n (%)) 64 (29.63) 53 (33.13) 11 (19.64) 0.16
 Chest pain/distress 51 (23.61) 27 (16.88) 24 (42.86) < 0.001
 Fever (n (%)) 26 (12.04) 24 (15.00) 2 (3.57) 0.048
 Amaurosis (n (%)) 25 (11.57) 21 (13.13) 4 (7.14) 0.46
 Weight loss (n (%)) 20 (9.26) 17 (10.63) 3 (5.36) 0.42
 Oral ulcer (n (%)) 12 (5.56) 6 (3.75) 6 (10.71) 0.04
 Cough/sputum (n (%)) 9 (4.17) 3 (1.88) 6 (10.71) 0.008
 Haemoptysis (n (%)) 5 (2.31) 2 (1.25) 3 (5.36) 0.092
Clinical signs
 Vascular murmur (n (%)) 68 (31.48) 46 (28.75) 22 (39.29) 0.087
 Hypertension (n (%)) 51 (23.61) 35 (21.88) 16 (28.57) 0.19
 Pulselessness/weak pulse (n (%)) 46 (21.30) 32 (20) 14 (25.00) 0.34
 Neck pain (n (%)) 14 (6.48) 11 (6.87) 3 (5.36) 0.21
 Claudication (n (%)) 13 (6.02) 7 (4.38) 6 (10.71) 0.09
Imaging features
 Aortic regurgitation (n (%)) 50 (23.15) 34 (21.25) 16 (28.57) 0.27
 Pulmonary hypertension (n (%)) 34 (15.74) 9 (5.63) 28 (50.00) < 0.001
 Type I 61 (28.24) 52 (32.5) 9 (16.07) 0.001
 Type IIa 12 (5.56) 9 (5.63) 3 (5.36)
 Type IIb 25 (11.57) 11 (6.88) 14 (25.00)
 Type III 12 (5.56) 12 (7.50) 0 (0)
 Type VI 12 (5.56) 10 (6.25) 2 (3.57)
 Type V 94 (43.52) 66 (41.25) 28 (50)
Laboratory results
 Haemoglobin (mean ± SD, g/L) 117.78 ± 20.18 117.70 ± 20.22 118.04 ± 20.24 0.92
 White blood cells (mean ± SD, 109/L) 9.29 ± 10.27 9.30 ± 11.05 9.24 ± 7.52 0.97
 Platelets (mean ± SD, 109/L) 287.33 ± 110.05 297.33 ± 111.67 256.94 ± 99.98 0.02
 Erythrocyte sedimentation rate (mmHg) 37.25 ± 33.84 38.66 ± 33.66 33.11 ± 34.33 0.31
 C-reactive protein (mg/L) 20.16 ± 31.31 21.40 ± 31.97 18.30 ± 29.41 0.54
 Interleukin-6 (pg/L) 10.16 ± 14.19 10.17 ± 13.95 10.11 ± 15.06 0.98

*P value: comparison between patients with and without pulmonary artery involvement (PAI)